We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $194.5M
Founded date: 2013
Investors 7
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
| - | S32 | s32.com |
| - | MRL Ventur... | mrlv.com |
| - | MBC BioLab... | mbcbiolabs... |
| - | Section 32 | section32.... |
| - | SV Health ... | svhealthin... |
| - | GV | gv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 27.07.2018 | Series E | $133M | - |
| 07.01.2016 | Series D | $29.5M | - |
| 16.09.2015 | Series C | $32M | - |
Mentions in press and media 27
| Date | Title | Description | Source |
| 16.03.2022 | Swapping out the brain’s cleanup crew treats neurological di... | From anemia to leukemia, unhealthy cells can make for unhealthy people, but replacing these cells ca... | statnews.c... |
| 24.03.2020 | Alector Announces the Appointment of Paula Hammond, Ph.D., t... | March 23, 2020 at 8:30 AM EDT SOUTH SAN FRANCISCO, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- Alect... | svhealthin... |
| 30.04.2019 | After amyloid failures, it’s time to take a new tack for tre... | If insanity is doing the same thing over and over again but expecting different results, then the la... | statnews.c... |
| 07.02.2019 | DDF Notes Alector's $176 million U.S. initial public offerin... | London, [7 February] 2019 - The Dementia Discovery Fund (“DDF”), a venture capital fund focused on d... | svhealthin... |
| 27.07.2018 | Biotech Company Alector Raises $133M in Series E Financing | Alector, a South Francisco, CA-based biotechnology company focused on developing therapies that harn... | finsmes.co... |
| 25.07.2018 | Alector raises $133 million in Series E round for neurology ... | The plan is to enter three drug candidates into the early next year, Chief Business Officer Sabah On... | medcitynew... |
| 25.07.2018 | Alector raises $133M in 5th VC round to push neuro-immunolog... | Previous Fierce 15 winner Alector has raised $133 million through a fifth round of venture capital f... | fiercebiot... |
| 25.07.2018 | Term Sheet — Wednesday, July 25 | 5 Qs WITH A DEALMAKER Fifth Wall Ventures has a pretty narrow investment thesis. It invests exclusi... | fortune.co... |
| 25.07.2018 | Alector Raises $133M Series E from Deerfield | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Alector, a privately held biotechnology company focuse... | citybizlis... |
| 25.07.2018 | DDF notes Alector raises $133 million in Series E Financing | The Dementia Discovery Fund notes that Alector, a privately held biotechnology company focused on de... | svhealthin... |
Show more